• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卒中后焦虑的患病率及其与总体认知障碍的关系:一项个体参与者数据分析。

Prevalence of poststroke anxiety and its associations with global cognitive impairment: An individual participant data analysis.

机构信息

Lille Neuroscience et Cognition, Degenerative and Vascular Cognitive Disorders Team, UMR-S 1172, INSERM, Lille F-59000, France.

Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, Australia.

出版信息

J Affect Disord. 2025 Jan 15;369:1136-1144. doi: 10.1016/j.jad.2024.10.099. Epub 2024 Oct 22.

DOI:10.1016/j.jad.2024.10.099
PMID:39447966
Abstract

BACKGROUND AND PURPOSE

Anxiety is frequent after stroke; however, little is known about its determinants. This study aims to assess the prevalence and correlates of post stroke anxiety (PSA) within 3-6 months following ischemic stroke.

METHODS

Three cohort studies from the STROKOG consortium were involved. Demographic and clinical data were standardized. PSA and PSD were assessed using inventories. The criteria for post-stroke cognitive impairment (PSCI) were at least one cognitive domain impaired if applicable, or a Montreal Cognitive Assessment (MoCA) score. Descriptive analyses were conducted to ascertain the prevalence of anxiety. Comparisons between anxious and non-anxious patients in the total sample were made using χ and t-tests. A two-step individual participant data (IPD) meta-analysis was employed to identify factors associated with PSA.

RESULTS

584 patients were included. The total prevalence of PSA was 35 % (95%CI = [31.23;38.97]) and ranged from 27 % to 45 % across cohorts. In the total sample, there was a higher proportion of females in the anxiety group than the non-anxiety group (χ = 19.62; p < 0.001). Anxious patients had lower education, (χ = 6.59; p = 0.03), higher stroke severity (t = 2.77; p = 0.002), and higher rates of PSD (χ = 118.09; p < 0.001), and PSCI (χ = 23.81, p < 0.001). The analysis demonstrates that the odds of presenting with PSA is larger in patients with PSCI (OR = 1.84, 95%CI = [1.14; 2.91]).

CONCLUSIONS

Anxiety is frequent after stroke, especially in females, and is associated with depression and cognitive impairment.

摘要

背景与目的

中风后常出现焦虑;然而,其决定因素知之甚少。本研究旨在评估缺血性中风后 3-6 个月内中风后焦虑(PSA)的发生率及其相关因素。

方法

本研究涉及 STROKOG 联盟的三个队列研究。对人口统计学和临床数据进行了标准化。使用量表评估 PSA 和 PSD。中风后认知障碍(PSCI)的标准为,如果适用,则至少一个认知域受损,或蒙特利尔认知评估(MoCA)评分。进行描述性分析以确定焦虑的发生率。在总样本中,比较焦虑患者和非焦虑患者,使用 χ 和 t 检验。采用两步个体参与者数据(IPD)荟萃分析,确定与 PSA 相关的因素。

结果

共纳入 584 例患者。PSA 的总发生率为 35%(95%CI=[31.23;38.97]),各队列间发生率为 27%-45%。在总样本中,焦虑组女性比例高于非焦虑组(χ=19.62;p<0.001)。焦虑患者的教育程度较低(χ=6.59;p=0.03),中风严重程度较高(t=2.77;p=0.002),抑郁(PSD)发生率较高(χ=118.09;p<0.001),以及认知障碍(PSCI)发生率较高(χ=23.81;p<0.001)。分析表明,存在 PSCI 的患者发生 PSA 的几率更大(OR=1.84,95%CI=[1.14;2.91])。

结论

中风后焦虑很常见,尤其是女性,且与抑郁和认知障碍有关。

相似文献

1
Prevalence of poststroke anxiety and its associations with global cognitive impairment: An individual participant data analysis.卒中后焦虑的患病率及其与总体认知障碍的关系:一项个体参与者数据分析。
J Affect Disord. 2025 Jan 15;369:1136-1144. doi: 10.1016/j.jad.2024.10.099. Epub 2024 Oct 22.
2
Post-stroke cognitive impairment remains highly prevalent and disabling despite state-of-the-art stroke treatment.尽管采用了最先进的中风治疗方法,但中风后的认知障碍仍然高度普遍且致残。
Int J Stroke. 2024 Oct;19(8):888-897. doi: 10.1177/17474930241238637. Epub 2024 Mar 21.
3
Incidence and Factors Associated With Cognitive Impairment 90 Days After First Ever Ischemic Stroke.首次缺血性卒中后90天认知障碍的发生率及相关因素
Int J Geriatr Psychiatry. 2025 May;40(5):e70087. doi: 10.1002/gps.70087.
4
Prevalence of depression and anxiety symptoms after stroke in young adults: A systematic review and meta-analysis.青年脑卒中后抑郁和焦虑症状的患病率:系统评价和荟萃分析。
J Stroke Cerebrovasc Dis. 2024 Jul;33(7):107732. doi: 10.1016/j.jstrokecerebrovasdis.2024.107732. Epub 2024 Apr 22.
5
Factors Influencing Poststroke Cognitive Dysfunction: Cross-Sectional Analysis.影响脑卒中后认知功能障碍的因素:横断面分析。
JMIR Form Res. 2024 Nov 19;8:e59572. doi: 10.2196/59572.
6
High Plasma Polyamine Levels Are Associated With an Increased Risk of Poststroke Cognitive Impairment: A Multicenter Prospective Study From CATIS.高血浆多胺水平与中风后认知障碍风险增加相关:来自CATIS的一项多中心前瞻性研究
J Am Heart Assoc. 2025 Jan 21;14(2):e037465. doi: 10.1161/JAHA.124.037465. Epub 2025 Jan 16.
7
Exploring the Relationship Between Serum Neuronal Pentraxin 2 and Poststroke Cognitive Impairment in Patients With First-Episode Acute Ischemic Stroke.探索首次发作急性缺血性脑卒中患者血清神经元五聚体蛋白2与卒中后认知障碍之间的关系。
Brain Behav. 2025 Feb;15(2):e70305. doi: 10.1002/brb3.70305.
8
Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts.卒中后认知障碍的策略性梗死部位:12 项急性缺血性卒中队列个体患者数据的汇总分析。
Lancet Neurol. 2021 Jun;20(6):448-459. doi: 10.1016/S1474-4422(21)00060-0. Epub 2021 Apr 23.
9
Sex Differences in Poststroke Cognitive Impairment: A Multicenter Study in 2343 Patients With Acute Ischemic Stroke.卒中后认知障碍的性别差异:2343 例急性缺血性卒中患者的多中心研究。
Stroke. 2023 Sep;54(9):2296-2303. doi: 10.1161/STROKEAHA.123.042507. Epub 2023 Aug 8.
10
Association of Depression and Anxiety With Cognitive Impairment 6 Months After Stroke.抑郁和焦虑与卒中 6 个月后认知障碍的相关性研究。
Neurology. 2021 Apr 13;96(15):e1966-e1974. doi: 10.1212/WNL.0000000000011748. Epub 2021 Feb 25.

引用本文的文献

1
Effects of private caregivers on nutritional risk and anxiety in stroke survivors with dysphagia: an observational study.私人护理人员对吞咽困难中风幸存者营养风险和焦虑的影响:一项观察性研究。
Front Nutr. 2025 May 30;12:1513609. doi: 10.3389/fnut.2025.1513609. eCollection 2025.
2
Edaravone dexborneol protected neurological function by targeting NRF2/ARE and NF-κB/AIM2 pathways in cerebral ischemia/reperfusion injury.依达拉奉右莰醇通过靶向脑缺血/再灌注损伤中的NRF2/ARE和NF-κB/AIM2信号通路来保护神经功能。
Front Pharmacol. 2025 Apr 25;16:1581320. doi: 10.3389/fphar.2025.1581320. eCollection 2025.